Dreyer Scott 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-03-03$40.36/sh−46,417$1,873,557→ 75,329 total - Sale
Common Stock
[F1][F3]2026-03-03$40.99/sh−3,559$145,879→ 71,770 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.835 to $40.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.84 to $41.35, inclusive.
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer|2026-03-05